Thanks roo. After filtering thru philbar's link re DNDN, it is clearer just how frought with danger investments in the biomedical field (in particular) can be.
Nevertheless your reasoned projections are welcomed as it would seem logical to expect a very volatile path based upon all the variables at play.
pbmd nasdaq 19 april, page-6
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
0.015(5.17%) |
Mkt cap ! $447.2M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 31.5¢ | 29.0¢ | $941.9K | 3.121M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 180750 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 322360 | 32 |
View Market Depth
| Last trade - 15.48pm 11/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |